212 related articles for article (PubMed ID: 36155113)
1. Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas.
Qian Y; Gong Y; Luo G; Liu Y; Wang R; Zou X; Deng S; Lin X; Chen Y; Wang X; Yu X; Cheng H; Liu C
World J Surg Oncol; 2022 Sep; 20(1):310. PubMed ID: 36155113
[TBL] [Abstract][Full Text] [Related]
2. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
3. Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.
Xu B; Ding WX; Jin DY; Wang DS; Lou WH
World J Gastroenterol; 2013 Mar; 19(9):1451-7. PubMed ID: 23539521
[TBL] [Abstract][Full Text] [Related]
4. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.
Fritz S; Hackert T; Hinz U; Hartwig W; Büchler MW; Werner J
Br J Surg; 2011 Jan; 98(1):104-10. PubMed ID: 20949535
[TBL] [Abstract][Full Text] [Related]
5. The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms.
Zhuge X; Zhou H; Chen L; Chen H; Chen X; Guo C
BMC Cancer; 2021 Nov; 21(1):1253. PubMed ID: 34800987
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
7. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
8. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas.
Sun LQ; Peng LS; Guo JF; Jiang F; Cui F; Huang HJ; Jin ZD
World J Gastroenterol; 2021 Feb; 27(6):501-512. PubMed ID: 33642824
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
12. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jang JY; Park T; Lee S; Kim Y; Lee SY; Kim SW; Kim SC; Song KB; Yamamoto M; Hatori T; Hirono S; Satoi S; Fujii T; Hirano S; Hashimoto Y; Shimizu Y; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Han HS; Yoon YS; Sho M; Nagano H; Honda G; Kim SG; Yu HC; Chung JC; Nagakawa Y; Seo HI; Yamaue H
Ann Surg; 2017 Dec; 266(6):1062-1068. PubMed ID: 27607098
[TBL] [Abstract][Full Text] [Related]
13. Serum elastase-1 predicts malignancy in intraductal papillary mucinous neoplasm of the pancreas.
Mishima T; Takano S; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Hosokawa I; Konishi T; Nishino H; Nakada S; Kouchi Y; Kishimoto T; Ohtsuka M
Pancreatology; 2024 Feb; 24(1):93-99. PubMed ID: 38102054
[TBL] [Abstract][Full Text] [Related]
14. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas.
Kanno A; Satoh K; Hirota M; Hamada S; Umino J; Itoh H; Masamune A; Asakura T; Shimosegawa T
J Gastroenterol; 2010 Sep; 45(9):952-9. PubMed ID: 20383536
[TBL] [Abstract][Full Text] [Related]
15. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
[TBL] [Abstract][Full Text] [Related]
17. Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases.
Oyama H; Hamada T; Nakai Y; Tanaka M; Endo G; Hakuta R; Ishida K; Ishigaki K; Kanai S; Kurihara K; Saito T; Sato T; Suzuki T; Suzuki Y; Takaoka S; Tange S; Tokito Y; Takahara N; Ushiku T; Fujishiro M
J Gastroenterol; 2023 Oct; 58(10):1068-1080. PubMed ID: 37507590
[TBL] [Abstract][Full Text] [Related]
18. [The value of preoperative CA19-9 combined with platelet-to-lymphocyte ratio in predicting invasive malignancy in intraductal papillary mucinous neoplasms].
Li JA; Han X; Fang Y; Zhang L; Lou WH; Xu XF; Wu WC; Kuang TT; Wang DS; Rong YF
Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):170-175. PubMed ID: 30861644
[No Abstract] [Full Text] [Related]
19. Predictive value of serum carbohydrate antigen 19-9 in malignant intraductal papillary mucinous neoplasms.
Xu B; Zheng WY; Jin DY; Ding WX; Lou WH; Ramsohok L
World J Surg; 2011 May; 35(5):1103-9. PubMed ID: 21416173
[TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
